Search research articles
Contact Us
Filters
Showing results (231-240 of 274) with videos related to
Page
of 28
Sort By:
Bone Marrow Transplantation
|
November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis
M L Riches, S Trifilio, M Chen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 7, 2004
Insulin sensitivity in physically fit and unfit children of parents with Type 2 diabetes
C W Ahn, Y D Song, J H Nam, et al.
Osteoarthritis and Cartilage
|
January 16, 2023
Arthroscopic partial meniscectomy vs non-surgical or sham treatment in patients with MRI-confirmed degenerative meniscus tears: a systematic review and meta-analysis with individual participant data from 605 randomised patients
S R W Wijn, G Hannink, H Østerås, et al.
Neurology
|
April 12, 2012
Influence of pregnancy on neuromyelitis optica spectrum disorder
W Kim, S-H Kim, I Nakashima, et al.
Transplantation
|
June 8, 2001
beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus
J H Nam, J I Mun, S I Kim, et al.
Diabetes, Obesity & Metabolism
|
January 11, 2016
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial
S Hong, C-Y Park, K A Han, et al.
Diabetes, Obesity & Metabolism
|
January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension
S-M Jin, C-Y Park, Y M Cho, et al.
Blood
|
July 1, 2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial
Michael A Pulsipher, Kwang W Ahn, Nancy J Bunin, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors
E M Newman, M Carroll, S A Akman, et al.
Hematological Oncology
|
January 10, 2017
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study
Narendranath Epperla, Mehdi Hamadani, Amanda F Cashen, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 274) with videos related to
Sort By:
Page
of 28
Bone Marrow Transplantation
|
November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis
M L Riches, S Trifilio, M Chen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 7, 2004
Insulin sensitivity in physically fit and unfit children of parents with Type 2 diabetes
C W Ahn, Y D Song, J H Nam, et al.
Osteoarthritis and Cartilage
|
January 16, 2023
Arthroscopic partial meniscectomy vs non-surgical or sham treatment in patients with MRI-confirmed degenerative meniscus tears: a systematic review and meta-analysis with individual participant data from 605 randomised patients
S R W Wijn, G Hannink, H Østerås, et al.
Neurology
|
April 12, 2012
Influence of pregnancy on neuromyelitis optica spectrum disorder
W Kim, S-H Kim, I Nakashima, et al.
Transplantation
|
June 8, 2001
beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus
J H Nam, J I Mun, S I Kim, et al.
Diabetes, Obesity & Metabolism
|
January 11, 2016
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial
S Hong, C-Y Park, K A Han, et al.
Diabetes, Obesity & Metabolism
|
January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension
S-M Jin, C-Y Park, Y M Cho, et al.
Blood
|
July 1, 2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial
Michael A Pulsipher, Kwang W Ahn, Nancy J Bunin, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors
E M Newman, M Carroll, S A Akman, et al.
Hematological Oncology
|
January 10, 2017
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study
Narendranath Epperla, Mehdi Hamadani, Amanda F Cashen, et al.
Page
of 28